Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,046 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06354959 | Prehab for Lung and Esophageal Cancer | recruiting | N/A | 25 | Nova Scotia Health AuthorityOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT01882205 | Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis | recruiting | N/A | 402 | Universitaire Ziekenhuizen KU LeuvenOTHER | 4 | Jul 10, 2024 | clinicaltrials |
| NCT02864485 | Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT05797831 | Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer | recruiting | Phase 2 / Phase 3 | 268 | Kartos Therapeutics, Inc.INDUSTRY | 17 | May 2, 2024 | clinicaltrials |
| NCT05068531 | Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients(eDetect-mCRC) | recruiting | — | 100 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06373419 | TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors | recruiting | N/A | 100 | Thunder Bay Regional Health Research InstituteOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04442516 | Cisplatin Induced Kidney Toxicity(ACCENT) | recruiting | — | 600 | The Hospital for Sick ChildrenOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06153147 | KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)(KINDEST-CCS) | recruiting | — | 500 | The Hospital for Sick ChildrenOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06349278 | Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX(PDAC-LIV) | recruiting | N/A | 15 | Laval UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04838899 | Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer | recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT02678884 | Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT05789901 | The MARVIN Chatbots to Provide Information for Different Health Conditions | recruiting | N/A | 400 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04104945 | p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)(PROTEcT) | recruiting | N/A | 32 | AHS Cancer Control AlbertaOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT03222895 | Distribution of Lymph Node Metastases in Esophageal Carcinoma(TIGER) | recruiting | — | 5,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 14 | Feb 13, 2024 | clinicaltrials |
| NCT05228106 | 68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study | recruiting | — | 1,000 | Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03225586 | Prospective Urban Rural Epidemiology Study(PURE) | recruiting | — | 200,000 | Population Health Research InstituteOTHER | 25 | Jan 31, 2024 | clinicaltrials |
| NCT04235114 | Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET) | recruiting | Phase 1 / Phase 2 | 14 | University of SaskatchewanOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT04459065 | Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery | recruiting | Phase 1 / Phase 2 | 36 | University of SaskatchewanOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05851547 | Dose Escalation For INtraprostatic LEsions(DEFINE) | recruiting | Phase 2 | 54 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT04050228 | Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer | recruiting | N/A | 240 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT05620290 | MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer | recruiting | Phase 1 | 20 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04050423 | Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses | recruiting | — | 1,200 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT04134780 | Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response | recruiting | — | 150 | Sunnybrook Health Sciences CentreOTHER | 2 | Dec 14, 2023 | clinicaltrials |
| NCT03908684 | Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers | recruiting | — | 320 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT04428515 | Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer | recruiting | — | 50 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT04428528 | Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy | recruiting | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT00437879 | Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment. | recruiting | — | 600 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT05863910 | Real World Evidence on the Use of Medical Cannabis in Pediatrics(CAN-RWE) | recruiting | — | 500 | University of ManitobaOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT05961124 | Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer | recruiting | Phase 2 | 40 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT05996653 | CEST in Low-grade Glioma Study | recruiting | N/A | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT03997643 | Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial | recruiting | Phase 2 | 90 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 4 | Aug 3, 2023 | clinicaltrials |
| NCT02193841 | Simple Bone Cysts in Kids(SBoCK) | recruiting | Phase 3 | 160 | The Hospital for Sick ChildrenOTHER | 4 | Jul 12, 2023 | clinicaltrials |
| NCT04654338 | 2 Ablative RadioTherapy Treatments for Prostate Cancer(EARTH) | recruiting | Phase 2 / Phase 3 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT04583254 | Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study | recruiting | Phase 2 | 48 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05326334 | THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)(THERABIOME-GBM) | recruiting | — | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04861415 | SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer(SHARP) | recruiting | N/A | 55 | Dr. Gerard MortonOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04920617 | DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma(VITALIZE) | recruiting | Phase 2 | 102 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 10 | Apr 7, 2023 | clinicaltrials |
| NCT03836196 | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease(OPTiMAL) | recruiting | N/A | 105 | British Columbia Cancer AgencyOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05673031 | 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors | recruiting | — | 500 | Alberta Health servicesOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05597852 | Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer(FIRST STAR) | recruiting | N/A | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05396560 | Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy(FIT2RUN) | recruiting | — | 3,000 | University of CalgaryOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT05314803 | Yoga for Young Adults Affected by Cancer | recruiting | N/A | 500 | University of CalgaryOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04478851 | EXCEL: Exercise for Cancer to Enhance Living Well(EXCEL) | recruiting | N/A | 1,500 | University of CalgaryOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04362046 | Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia(FETCH) | recruiting | N/A | 30 | Vancouver Coastal Health Research InstituteOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT04220749 | Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma | recruiting | Phase 2 | 68 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT03838718 | REtroperitoneal SArcoma Registry: an International Prospective Initiative(RESAR) | recruiting | — | 2,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Feb 12, 2019 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials